Your participation in this study will require 7 total visits over approximately 2 months.
You will receive one of 5 various doses on each visit. 4 of these doses will be of the study drug,
and one will be a placebo, otherwise known as an inactive substance (such as a sugar pill). This is a double-blind study, meaning neither you nor the study doctor and staff will know to which of these groups you have been assigned to. However, in case of an emergency, the study doctor can get this information.
After Study Treatment:
You will be called approximately 1 month after this follow-up visit to assess for possible long-term effects (if any).